[D-Phe12]-Bombesin

CAS No. 108437-87-2

[D-Phe12]-Bombesin( ——— )

Catalog No. M42097 CAS No. 108437-87-2

[D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 423 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Phe12]-Bombesin
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.
  • Description
    Bombesin receptor antagonist
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bombesin receptor
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    108437-87-2
  • Formula Weight
    1629.88
  • Molecular Formula
    C74H112N22O18S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Heinz-Erian P, et al., D-Phe12bombesin analogues: a new class of bombesin receptor antagonists. Am J Physiol. 1987 Mar;252(3 Pt 1):G439-42. ?
molnova catalog
related products
  • Bim BH3, Peptide IV ...

    Bim BH3, Peptide IV TFA is a 26-site residue of BH3 protein Bim, belonging to the pro-apoptotic group of bcl-2 protein family.

  • Alnustone

    Alnustone exerts significant anti-inflammatory activity in the assay of carrageenin-induced hind paw edema in rats.

  • 116-9e

    116-9e (MAL2-11B) is a potent Hsp70 co-chaperone DNAJA1 inhibitor with antiviral properties, inhibiting simian virus 40 (SV40) replication, tumour antigen (TAg) endogenous ATPase activity, and TAg-mediated activation of Hsp70. 116-9e can be used to study cancer drug resistance.